Your browser doesn't support javascript.
loading
The Reconstitution of T-cells after Allogeneic Hematopoietic Stem Cell Transplant in a Pediatric Patient with Congenital Amegakaryocytic Thrombocytopenia (CAMT).
Bayegi, Shideh Namazi; Hamidieh, Amir Ali; Behfar, Maryam; Saghazadeh, Amene; Bozorgmehr, Mahmood; Tajik, Nader; Delbandi, Ali-Akbar; Delavari, Samaneh; Shekarabi, Mehdi; Rezaei, Nima.
Affiliation
  • Bayegi SN; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Saghazadeh A; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Bozorgmehr M; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Tajik N; Systematic Review and Metaanalysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Delbandi AA; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Delavari S; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Shekarabi M; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
  • Rezaei N; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Article de En | MEDLINE | ID: mdl-37526450
ABSTRACT

BACKGROUND:

Congenital amegakaryocytic thrombocytopenia (CAMT) is a bone marrow failure syndrome with autosomal recessive inheritance characterized by the lack of megakaryocytes and thrombocytopenia. The cause of the disease is a mutation in the c-Mpl gene, which encodes the thrombopoietin (TPO) receptor. The main treatment for this genetic disorder is an allogeneic hematopoietic stem cell transplant (allo-HSCT). However, transplant-related mortality, development of acute and chronic graft-versushost disease (GvHD), and susceptibility to opportunistic infections are major barriers to transplantation. Delay in the reconstitution of T cells and imbalance in the regeneration of distinct functional CD4 and CD8 T-cell subsets mainly affect post-transplant complications. We report a case of CAMT, who developed acute GvHD but had no signs and symptoms of chronic GvHD following allo-HSCT. CASE PRESENTATION At the age of four, she presented with petechiae and purpura. In laboratory investigations, pancytopenia without organomegaly, and cellularity less than 5% in bone marrow biopsy, were observed. A primary diagnosis of idiopathic aplastic anemia was made, and she was treated with prednisolone, cyclosporine, and anti-thymocyte globulin (ATG), which did not respond. Genetic analysis revealed the mutation c.1481T>G (p. L494W) in exon 10 of the c-Mpl gene, and the diagnosis of CAMT was confirmed. The patient underwent allo-HSCT from a healthy sibling donor. Alloimmunization reactions and immune disorders were present due to long-term treatment with immunosuppressive medications and repeated blood and platelet transfusions. Hence, the regeneration of T-lymphocytes after allo-HSCT was evaluated.

CONCLUSION:

Successful treatment of acute GvHD prevented advancing the condition to chronic GvHD, and this was accompanied by delayed T-cell reconstitution through an increase in TregTcons ratio.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thrombopénie / Transplantation de cellules souches hématopoïétiques / Insuffisances médullaires congénitales / Maladie du greffon contre l'hôte Limites: Child / Female / Humans Langue: En Journal: Endocr Metab Immune Disord Drug Targets Sujet du journal: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Année: 2024 Type de document: Article Pays d'affiliation: Iran

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Thrombopénie / Transplantation de cellules souches hématopoïétiques / Insuffisances médullaires congénitales / Maladie du greffon contre l'hôte Limites: Child / Female / Humans Langue: En Journal: Endocr Metab Immune Disord Drug Targets Sujet du journal: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Année: 2024 Type de document: Article Pays d'affiliation: Iran